PA
MNTN

PharVision Advisers’s MNTN Inc MNTN Stock Holding History

PharVision Advisers’s Portfolio MNTN Stock Details MNTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-26,288
Closed -$314K – 698
2025
Q4 		$314K Buy
+26,288
New +$379K 0.16% 244

Other funds holding MNTN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MML
Mercato Management Legacy Cottonwood Heights, Utah $54.3M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
G
Greycroft New York $146M AUM 1.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PharVision Advisers's MNTN Position: Q1 2026 in Review

PharVision Advisers sold out of MNTN Inc (MNTN) in Q1 2026, closing a stake of 26,288 shares — an estimated $314K sold.

PharVision Advisers first reported a position in MNTN in Q4 2025 and held it in 1 quarter. The position peaked at $314K in Q4 2025. 95 funds tracked by Wall St. Rank hold MNTN as of Q1 2026.

  • PharVision Advisers reported no remaining MNTN Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 26,288 MNTN Inc shares in Q1 2026, an estimated $314K.
  • PharVision Advisers first reported a position in MNTN Inc in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's MNTN Inc position peaked at $314K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held MNTN Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.